IL36239A - 4-hydroxy-4-) 2-oxo-3-tetrahydroporil (piperidine and its preparation - Google Patents

4-hydroxy-4-) 2-oxo-3-tetrahydroporil (piperidine and its preparation

Info

Publication number
IL36239A
IL36239A IL6836239A IL3623968A IL36239A IL 36239 A IL36239 A IL 36239A IL 6836239 A IL6836239 A IL 6836239A IL 3623968 A IL3623968 A IL 3623968A IL 36239 A IL36239 A IL 36239A
Authority
IL
Israel
Prior art keywords
formula
hydroxy
tetrahydrofuryl
oxo
piperidine
Prior art date
Application number
IL6836239A
Other languages
English (en)
Hebrew (he)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL36239A publication Critical patent/IL36239A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL6836239A 1967-04-19 1968-04-17 4-hydroxy-4-) 2-oxo-3-tetrahydroporil (piperidine and its preparation IL36239A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH558967A CH497458A (de) 1967-04-19 1967-04-19 Verfahren zur Herstellung neuer Phenothiazin-Derivate
CH1705667 1967-12-05

Publications (1)

Publication Number Publication Date
IL36239A true IL36239A (en) 1971-06-23

Family

ID=25698043

Family Applications (2)

Application Number Title Priority Date Filing Date
IL6836239A IL36239A (en) 1967-04-19 1968-04-17 4-hydroxy-4-) 2-oxo-3-tetrahydroporil (piperidine and its preparation
IL6829842A IL29842A (en) 1967-04-19 1968-04-17 History of phenothiazine

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL6829842A IL29842A (en) 1967-04-19 1968-04-17 History of phenothiazine

Country Status (17)

Country Link
US (1) US3531480A (no)
AT (2) AT292726B (no)
AU (2) AU5480273A (no)
BE (1) BE713802A (no)
BG (1) BG17326A3 (no)
CH (1) CH497458A (no)
DE (1) DE1770218A1 (no)
ES (1) ES352822A1 (no)
FR (1) FR1583822A (no)
GB (2) GB1223315A (no)
IE (2) IE32169B1 (no)
IL (2) IL36239A (no)
NL (1) NL6804983A (no)
NO (1) NO124997B (no)
OA (1) OA03386A (no)
RO (1) RO54395A (no)
SE (2) SE356520B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857943A (en) * 1969-03-27 1974-12-31 May & Baker Ltd New phenothiazine derivatives in the treatment of spasticity of muscles
CH511886A (de) * 1969-07-08 1971-08-31 Sandoz Ag Verfahren zur Herstellung neuer Furanonderivate
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
US6310059B1 (en) 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
WO2007133481A2 (en) * 2006-05-11 2007-11-22 Neuromed Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
JP2014507424A (ja) 2011-03-08 2014-03-27 ザリカス ファーマスーティカルズ リミテッド 固体分散物製剤およびその使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1212031A (fr) * 1957-10-21 1960-03-21 Rhone Poulenc Sa Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation

Also Published As

Publication number Publication date
SE356520B (no) 1973-05-28
US3531480A (en) 1970-09-29
FR1583822A (no) 1969-12-05
GB1223314A (en) 1971-02-24
IE32170L (en) 1968-10-19
IE32169B1 (en) 1973-05-02
GB1223315A (en) 1971-02-24
DE1770218A1 (de) 1971-10-14
RO54395A (no) 1973-02-17
AU5480173A (en) 1973-07-12
IL29842A0 (en) 1968-06-20
BG17326A3 (no) 1973-07-25
IE32170B1 (en) 1973-05-02
AU5480273A (en) 1973-07-12
AT292726B (de) 1971-09-10
IE32169L (en) 1968-10-19
IL29842A (en) 1971-05-26
AT293372B (de) 1971-10-11
CH497458A (de) 1970-10-15
NL6804983A (no) 1968-10-21
OA03386A (fr) 1970-12-15
NO124997B (no) 1972-07-03
ES352822A1 (es) 1969-11-16
SE361884B (no) 1973-11-19
BE713802A (no) 1968-10-17

Similar Documents

Publication Publication Date Title
NO140977B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
IL36239A (en) 4-hydroxy-4-) 2-oxo-3-tetrahydroporil (piperidine and its preparation
NO125911B (no)
JPS6113472B2 (no)
SU843749A3 (ru) Способ получени 4а,9в-транс- гЕКСАгидРО- -КАРбОлиНА
IE43847B1 (en) N-substituted phenyl-piperidine derivatives
Toki Studies on sarkomycin–optically active 2-methylenecyclopentanone-3-carboxylic acids
US2678317A (en) N - benzhydryltropylamine com
US4087426A (en) Oxybisberberine and a process for its production
US3466298A (en) Process for the preparation of 2-(2-aminoethyl)isoindolines
Akkerman et al. Synthetic oxytocics. IV. 3‐(piperidyl‐(2)‐methyl‐) indoles and related compounds
US3072648A (en) X-phenyl-s
US3462443A (en) Indeno(1,2-c)pyridine derivatives
US3073826A (en) 3-pyrrolidylmethyl-4-quinazolones
US2956058A (en) Novel substituted piperidines and pyrrolidines
JP4994772B2 (ja) ビスアミノールエーテル化合物を用いるピペリジン−4−オン誘導体の製造方法
US2951080A (en) Novel phenyl-substituted piperidines
US2931805A (en) Spiro [bicyclo [2. 2. 1] heptane-2, 2'-alkylenimines]
IE41462B1 (en) Piperidyl-methylenedioxybenzene derivatives
US3086972A (en) Aza-thiaxanthene derivatives
GRUNDMANN et al. Triazines. XVII. s-Triazine from s-Triazine-2, 4, 6-tricarbonic Acid
NO139050B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
US3037986A (en) 2-(para-methoxyphenylcarbinol)-1-(phenylalkyl) piperidinium hydrobromide
Belleau SYNTHESIS IN THE FIELD OF THE ERYTHRINA ALKALOIDS: PART II. APPROACHES TO THE RING SYSTEM OF β-ERYTHROIDINE
NO762085L (no)